2Lyora is a specialty pharmaceutical company in formation, focused on the commercialization and lifecycle management of transformative 'one-and-done' therapies. Its mission is to ensure sustained patient access, supply continuity, and distribution support for advanced therapies beyond their initial peak sales phase - when markets shift from prevalent to incident populations, and market access pressures intensify.